The Indian Journal of Ophthalmology is a prestigious, peer-reviewed publication dedicated to advancing the field of ophthalmology. Published by Wolters Kluwer Medknow Publications, this journal plays a vital role in disseminating high-quality research and clinical insights since its inception in 1946. With an impact factor placing it in the Q2 category in Ophthalmology for 2023, it ranks #42 out of 137 in Scopus, reflecting its influence and reliability in the medical community. As an Open Access journal since 2005, it ensures that impactful research is accessible to a global audience, fostering innovation and knowledge sharing among researchers, healthcare professionals, and students alike. The journal's commitment to publishing cutting-edge studies, comprehensive reviews, and clinical guidelines makes it an essential resource for those navigating the rapidly evolving landscape of eye care and ophthalmology.

The Middle East African Journal of Ophthalmology is a distinguished publication dedicated to advancing knowledge in the field of ophthalmology, published by Wolters Kluwer Medknow Publications in India. With a robust focus on contributions that bridge the gap between clinical practices and scientific research, this journal serves as a crucial platform for researchers, practitioners, and students alike. Since its inception, it has consistently disseminated high-impact research, achieving notable recognition with a Q3 ranking in both Medicine (miscellaneous) and Ophthalmology categories as of 2023. Despite being a newer entrant into the scholarly landscape, it features an array of innovative articles, highlighting significant advancements and emerging trends in ocular health. Researchers may access a wealth of knowledge through its open access articles, promoting the dissemination of vital ophthalmic research that is relevant in both Middle Eastern and African contexts. By fostering collaboration and communication among professionals in the field, the Middle East African Journal of Ophthalmology is committed to championing excellence in eye care and elevating the standard of research applicable to global populations.

Journal of the Egyptian Ophthalmological Society is a premier academic journal dedicated to advancing the field of ophthalmology through high-quality peer-reviewed research. Published by Wolters Kluwer Medknow Publications, this journal plays a critical role in disseminating vital findings and innovations in eye care, fostering knowledge exchange among researchers, practitioners, and educators worldwide. Since its transformation to Open Access in 2014, it has significantly enhanced the accessibility of eye health information, thereby broadening its impact on the global scientific community. With an ISSN of 2090-0686 and an E-ISSN of 2314-6648, the journal aims to tackle contemporary issues in ophthalmology, including clinical practices, public health, and technological advancements in eye care. The journal's commitment to excellence ensures that it remains a vital resource for those looking to contribute meaningfully to this dynamic and crucial field.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, published by Springer, has established itself as a premier journal in the field of ophthalmology since its inception in 1870. With an ISSN of 0721-832X and an E-ISSN of 1435-702X, this esteemed journal enjoys a notable impact in the research community, ranking Q1 in Ophthalmology and Q1 in Sensory Systems, as per the latest 2023 journal category quartiles. GRAEFES Archive is dedicated to advancing our understanding of ocular health through both clinical and experimental studies, making it an essential resource for researchers, practitioners, and students alike. Its comprehensive scope covers various aspects of ophthalmic science, reflecting its long-standing commitment to quality and excellence. Although it currently operates on a subscription basis, the journal's significant Scopus rankings—24th out of 137 in Ophthalmology—underscore its relevance and influence within the scientific community. Situated in Germany, with its address in the United States, this international journal continues to shape the discourse on vision science and therapeutic innovation.

Canadian Journal of Ophthalmology - Journal Canadien d'Ophtalmologie, published by the prestigious Canadian Ophthalmological Society, serves as a leading platform for disseminating cutting-edge research in the field of ophthalmology. With an ISSN of 0008-4182 and E-ISSN 1715-3360, the journal boasts a commendable impact factor and maintains a strong presence within the medicine and ophthalmology categories, ranking in the Q2 quartile. This journal not only provides significant insights into clinical practices and advancements but also contributes to the understanding of ocular health issues facing contemporary society. Since its inception in 1966, it has published high-quality research, making substantial strides in both practical and theoretical aspects of ophthalmology until 2024. Although it is not an open-access journal, it establishes a vital resource for researchers, professionals, and students alike, fostering an informed community dedicated to improving vision care.

Nepalese Journal of Ophthalmology, established by the NEPAL OPHTHALMIC SOC, is a premier Open Access journal dedicated to advancing the field of ophthalmology. With its ISSN 2072-6805 and E-ISSN 2091-0320, the journal provides an important platform for sharing innovative research and clinical findings in eye health. Since its inception in 2009, the journal has aimed to disseminate high-quality research that addresses contemporary challenges in ophthalmic practices, thus supporting improved patient care and outcomes within Nepal and beyond. The journal has achieved notable recognition, evidenced by its Scopus rank of #267 out of 915 in the field of General Medicine, placing it within the 70th percentile. Researchers, professionals, and students will find valuable information in its comprehensive articles, which cater to a multidisciplinary audience interested in the latest developments in ophthalmology. Emphasizing accessibility, the journal ensures that all published content is freely available, fostering collaboration and knowledge sharing in the global medical community.

Ophthalmology Glaucoma is a premier academic journal dedicated to advancing the understanding and management of glaucoma, a leading cause of irreversible blindness worldwide. Published by Elsevier, this journal covers a broad spectrum of topics within the field of ophthalmology, providing a platform for groundbreaking research and clinical insights. With an impressive impact factor that places it in the Q1 category of ophthalmology journals, and a commendable Scopus ranking of 29 out of 137, Ophthalmology Glaucoma is recognized for its rigorous peer-review process and high-quality publications. Since its inception in 2018, the journal has focused on disseminating innovative findings and treatment modalities to enhance patient care and outcomes. Researchers, clinicians, and students are encouraged to explore the Open Access options available, promoting wider accessibility to critical scientific knowledge. By staying at the forefront of ophthalmic research, Ophthalmology Glaucoma plays an essential role in shaping practices and policies that improve eye health globally.

Ophthalmology and Therapy is a premier open-access journal published by Springer International Publishing AG, dedicated to advancing the field of ophthalmology through innovative research and clinical studies. With an ISSN of 2193-8245 and an E-ISSN of 2193-6528, this journal serves as a vital resource for researchers, healthcare professionals, and students interested in the latest developments in eye care and vision science. The journal has achieved a remarkable impact factor and has been recognized as a Q1 journal in Ophthalmology, reflecting its contributions to the discipline and its high-quality publications. Operating from the United Kingdom, Ophthalmology and Therapy is an open-access platform that has been available since 2012, ensuring that critical research is accessible to a global audience. Its commitment to fostering collaboration and knowledge sharing is exemplified by its ranking of #39 out of 137 in the Scopus category for Medicine – Ophthalmology, placing it in the 71st percentile of its peers. Together, these attributes highlight the journal's importance as a key forum for the dissemination of cutting-edge research, making it an essential addition to the libraries of institutions and professionals engaged in ophthalmic care.

Clinical Ophthalmology is a leading Open Access journal published by Dove Medical Press Ltd, dedicated to advancing the field of ophthalmology through peer-reviewed research and clinical studies. With a strong impact factor and ranked in the Q1 category of ophthalmology as of 2023, this journal is recognized for its significant contribution to the body of knowledge pertaining to eye health, vision science, and clinical practice. Its Scopus ranking places it within the top 30% of journals in the field, reflecting its influence and relevance in both academic and clinical landscapes. Since its inception in 2007, Clinical Ophthalmology has established a reputation for fostering high-quality research, providing a platform for researchers, professionals, and students to share their findings and insights. The journal's commitment to open access ensures that groundbreaking research is freely available to the global community, supporting innovation and collaboration in the pursuit of better patient outcomes worldwide. For those engaged in ophthalmological research and clinical practice, Clinical Ophthalmology serves as an invaluable resource and a hub for the latest developments in the field.

Welcome to Spektrum der Augenheilkunde, a distinguished journal published by SPRINGER WIEN, dedicated to the field of ophthalmology since its inception in 1987. With an ISSN of 0930-4282 and an E-ISSN of 1613-7523, this journal is recognized for its commitment to publishing original research, reviews, and clinical studies that address current and emerging topics in eye health and treatment. Although classified in the Q4 category for ophthalmology as per the latest 2023 rankings, it serves as a valuable platform for researchers, professionals, and students looking to contribute to and expand their knowledge in this vital area of medicine. Based in Austria and accessible through various academic databases, the journal aims to foster communication among professionals and advance the understanding of ocular diseases, innovative therapies, and clinical best practices.